DAPAgliflozine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DAPAgliflozine, covering 2025-12-19 to 2025-12-19. Get the full timeline:
Most recent: Clinical Trial Update: DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction [Phase 3]